Peregrine Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.1M | 636k | 6.50 |
| 2023-09-30 | $2.7M | 290k | 9.44 |
| 2023-06-30 | $5.3M | 378k | 13.97 |
| 2023-03-31 | $7.8M | 415k | 18.76 |
| 2022-12-31 | $6.2M | 450k | 13.77 |
| 2022-06-30 | $5.3M | 350k | 15.26 |
| 2022-03-31 | $8.5M | 416k | 20.37 |
| 2021-12-31 | $16M | 532k | 29.18 |
| 2021-09-30 | $17M | 800k | 21.57 |
| 2021-03-31 | $15M | 800k | 18.22 |
| 2020-12-31 | $4.6M | 403k | 11.54 |
| 2020-09-30 | $1.1M | 146k | 7.62 |
| 2020-06-30 | $809k | 123k | 6.56 |
| 2019-12-31 | $1.4M | 179k | 7.67 |
| 2019-09-30 | $2.1M | 404k | 5.30 |
| 2019-06-30 | $107k | 19k | 5.58 |
| 2019-03-31 | $148k | 35k | 4.27 |
| 2018-12-31 | $339k | 83k | 4.09 |
| 2018-09-30 | $342k | 50k | 6.85 |
| 2018-03-31 | $208k | 71k | 2.92 |